Home > Insider Trading > Filing (0001209191-19-055036)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1673772	Rapt Therapeutics Inc.	RAPT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1182464	V David Goeddel	C/O Rapt Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA 94080		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-04	2,463,659	$0.00	2,463,659	No	4	C	Indirect	By The Column Group II, LP
Common Stock	Acquisiton	2019-11-04	1,166,666	$0.00	3,630,325	No	4	C	Indirect	By The Column Group II, LP
Common Stock	Acquisiton	2019-11-04	727,008	$0.00	4,357,333	No	4	C	Indirect	By The Column Group II, LP
Common Stock	Acquisiton	2019-11-04	625,000	$12.00	4,982,333	No	4	P	Indirect	By The Column Group II, LP
Common Stock	Acquisiton	2019-11-04	1,454,016	$0.00	1,454,016	No	4	C	Indirect	By Ponoi Capital, LP
Common Stock	Acquisiton	2019-11-04	145,401	$0.00	1,599,417	No	4	C	Indirect	By Ponoi Capital, LP
Common Stock	Acquisiton	2019-11-04	145,401	$0.00	145,401	No	4	C	Indirect	By Ponoi Capital II, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By The Column Group II, LP
No	4	C	Indirect	By The Column Group II, LP
No	4	C	Indirect	By The Column Group II, LP
No	4	P	Indirect	By The Column Group II, LP
No	4	C	Indirect	By Ponoi Capital, LP
No	4	C	Indirect	By Ponoi Capital, LP
No	4	C	Indirect	By Ponoi Capital II, LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-11-04	14,781,963	$0.00	2,463,659	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-11-04	7,000,000	$0.00	1,166,666	$0.00
Common Stock	Series C Preferred Stock	Disposition	2019-11-04	4,362,050	$0.00	727,008	$0.00
Common Stock	Series C Preferred Stock	Disposition	2019-11-04	8,724,100	$0.00	1,454,016	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2019-11-04	872,410	$0.00	145,401	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2019-11-04	872,410	$0.00	145,401	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	50,000	Indirect	By The Column Group II Management, LP

Footnotes

At the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, and Series C-2 Preferred Stock of the Issuer automatically converted into approximately 0.166 shares of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-6 reverse stock split of the common stock effected by the Issuer on July 19, 2019) for no additional consideration. Shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series C-2 Preferred Stock have no expiration date.
David Goeddel is a managing partner of The Column Group II GP, LP, which is the general partner of The Column Group II, LP. Dr. Goeddel is also a managing partner of The Column Group II Management, LP. Dr. Goeddel is also a managing partner of Ponoi Management, LLC, general partner of Ponoi Capital, LP, and a managing partner of Ponoi II Management, LLC, general partner of Ponoi Capital II, LP. Dr. Goeddel may be deemed to share voting and investment power with respect to the shares reported herein and disclaims beneficial ownership of the shares except to the extent of his pecuniary interests therein.
These shares are held directly by The Column Group II, LP.
These shares are held directly by Ponoi Capital, LP.
These shares are held directly by Ponoi Capital II, LP.
These shares are held directly by The Column Group II Management, LP.